No Data
No Data
Bionano Genomics Announces Use of OGM in Preimplantation Genetic Testing
Bionano Announces Publication Of A Case Study From The Shenzhen Maternity And Child Healthcare Hospital, China, Demonstrating The Application Of Optical Genome Mapping In A Protocol For Preimplantation Genetic Testing For Structural Rearrangements
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss
8-K: Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
Bionano Preliminary Revenue For Q4 2024 Expected Between $7.9M-$8.1M Despite 25% Decrease; Optical Genome Mapping Systems Increase By 14% To 371 Units; Nanochannel Array Flowcells Sales Rise 1% To 8,058 Units
Press Release: Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results
No Data